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Evidence base of clinical diagnosis
Designing studies to ensure that estimates of test accuracy
are transferable
Les Irwig, Patrick Bossuyt, Paul Glasziou, Constantine Gatsonis, Jeroen Lijmer
Measures of test accuracy are often thought of as fixed
characteristics determinable by research and then
applicable in practice. Yet even when tests are
evaluated in a study of adequate quality—one including
such features as consecutive patients, a good reference
standard, and independent, blinded assessments of
tests and the reference standard1—performance of a
diagnostic test in one setting may vary significantly
from the results reported elsewhere.2–8 In this paper, we
explore the reasons for this variability and its implica›
tions for the design of studies of diagnostic tests.
True variability in test accuracy
To interpret a test’s results in different setting requires
an understanding of whether and why the test’s
accuracy varies. Broadly speaking, measures of
accuracy fall into two broad categories: measures of
discrimination between people who are and who are
not diseased, and measures of prediction used to
estimate post›test probability of disease.
Measures of discrimination
Global measures of test accuracy assess only the ability
of the test to discriminate between people with and
without a disease. Common examples are the area
under the receiver operating characteristic curve
(ROC), and the odds ratio (OR), sometimes also
referred to as the diagnostic odds ratio. Such results
may suffice for some broad health policy decisions—for
example, to decide whether a new test is in general
better than an existing test for the target condition.
Measures for prediction
The measures used to estimate the probabilities of the
target condition in people who have a particular test
result require both discrimination and calibration. The
predictive value—the proportion of people with a par›
ticular test result who have the disease of interest—is an
example. It is clumsy and difficult to estimate disease
rates for categories of patients who may have different
pretest probabilities of having the disease. Therefore,
the estimation is often done indirectly using Bayes’s
theorem, based on the pretest probability and
measures of test characteristics such as sensitivity and
specificity or likelihood ratios in specific patients. These
measures of test performance require more than
discrimination. They require tests to be calibrated.
Transferability of test results
The transferability of measures of test performance
from one setting to another depends on which indica›
tor of test performance is used. The figure shows the
assumptions involved in transferability. The table indi›
cates the relation between these assumptions and the
transferability of the different measures of test
performance.
The main assumptions in transferring tests across
settings fall into six categories.
The definition of disease is constant—Many diseases
have ambiguous definitions. For example, there are
no single reference standards for heart failure,
Alzheimer’s disease, or diabetes. Reference standards
may differ because individual investigators’ conceptual
frameworks differ, or because it is difficult to apply the
same framework in a standardised way.
The same test is used—Although based on the same
principle, tests may differ—for example, over time or if
made by different manufacturers.
The thresholds between categories of test result (for exam›
ple, positive and negative) are constant—This is possible
with a well standardised test that can be calibrated for
different settings. However, there may be no accepted
means of calibration—for example, different observers
of imaging tests may have different thresholds for call›
ing an image “positive.” The effect of different cut›off
points is classically studied by use of a receiver operat›
ing characteristic curve. In some cases calibration may
be improved by using category specific likelihood
ratios rather than a single cut›off point.
Summary points
Test accuracy may vary considerably from one
setting to another
This may be due to the target condition, the
clinical problem, what other tests have been done,
or how the test is carried out
Larger studies than those usually done for
diagnostic tests will be needed to assess
transferability of results
These studies should explore the extent to which
variation in test accuracy between populations
can be explained by patient and test features
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Distribution of test results in patients with and without the target
disease. The numbers refer to assumptions for the transferability of
test results (see text and table)
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The distribution of test results in the disease group is
constant in average (location) and spread (shape)—This
assumption is not fulfilled if the spectrum of disease
changes—if, for example, a screening setting is likely to
include earlier disease, for which test results will be
closer to those for a group without the disease (hence
reducing sensitivity).
The distribution of test results in the group without dis›
ease is constant in average (location) and spread
(shape)—This assumption is not fulfilled if the spectrum
of non›disease changes—if, for example, the secondary
care setting involves additional causes of false positives
due to comorbidity not seen in primary care.
The ratio of disease to non›disease (pretest probability) is
constant—If this were the case, we could use the
post›test probability (“predictive” values) directly. How›
ever, this assumption is often not fulfilled—for
example, the pretest probability is likely to be lowest
with screening tests and greatest with tests in referred
patients. This likely inconstancy is the reason for using
Bayes’s theorem to “adjust” the post›test probability for
the pretest probability of each different setting.
All measures of test performance need the first two
assumptions to be fulfilled. The importance of the last
four assumptions is shown in the table, although they
may not be necessary in every instance; occasionally
the assumptions may not be fulfilled but, because
of compensating differences, transferability is still
reasonable.
Assessing transferability of
discrimination and prediction
How should a study be designed to ensure that its
transferability can be determined? We need first to dis›
tinguish artefactual variation from real variation in
diagnostic performance. Artefactual variation arises
when studies vary in the extent to which they share
design features, such as whether consecutive patients
were included or the reference standard and index test
were read blind to each other. Once such sources of
variation have been ruled out, we may explore the
potential sources of true variation.9 The issues to
consider are similar to those for assessing interven›
tions. For interventions, we consider patient, interven›
tion, comparator, and outcome (PICO).10 11 To ensure
that readers have the necessary information to decide
on the transferability of a diagnostic study to their own
setting, five components need to be taken into account
in design and presentation of a study.
Target condition and reference standard
The target condition and reference standard need to be
carefully chosen. For example, in a study of clinically
relevant tests to assess stenosis of the carotid artery, it
would be sensible to dichotomise angiographic stenosis
at the level of angiographic abnormality above which,
on currently available evidence, the benefits of treat›
ment outweigh harm, and to use this as the reference
standard. Error in the reference standard should be
minimised—for example, by better methods or multiple
assessments. Any information about the accuracy of the
reference standard will help interpretation.
Discriminative or predictive measures?
Assessment of the discrimination of a test requires
measures such as the area under the receiver operating
characteristic curve or diagnostic odds ratio. However,
for estimating the probability of disease in individuals,
likelihood ratios (or sensitivity and specificity) are
needed, with additional information on how the tests
were calibrated. Studies should include information
about calibration; inclusion of selected example mate›
rial, such as x rays of lesions, will help to clarify what
thresholds have been used.
Clinical problem and population
This question defines how the initial cohort should be
selected for study—for example, a new test for carotid
stenosis could be considered for all patients referred to a
surgical unit. However, ultrasound quantifies the extent
of a stenosis reasonably accurately, so investigators may
choose to restrict the study of a more expensive or inva›
sive test to patients in whom the ultrasound result is near
the decision threshold for surgery. A useful planning
tool is to draw a flow diagram of how patients are
selected to make up the population with the clinical
problem of interest. This flow diagram shows what clini›
cal information has been gathered, what tests have been
done, and how the results of those tests determine entry
into the population in which the clinical problem of
interest is being studied. A good example is given in a
recent paper on the assessment of imaging tests in the
diagnosis of appendicitis in children.12
Replacement or incremental value of the test?
A key question is whether a test is being assessed as a
replacement (substitution) for an existing test (because
it is better or just as good and cheaper) or whether the
test adds value when used in addition to specified exist›
ing tests. This decision will also be a major determinant
of how the data should be analysed.13–15
Assumptions for transferring different test performance characteristics (X=important; x=less important)
Assumption*
Comment3 4 5 6
Measures of test’s discriminatory power
Odds ratio X X X Used for global assessment of discriminatory power and are transferable if
assumptions are met. Neither is concerned with calibration and therefore
they cannot be used for assessing probability of disease in individualsArea under ROC X X
Measures of discriminatory power and calibration
Predictive value X X X X Directly estimates probability of disease in individuals
Sensitivity X X x
Can be used to estimate probability of disease in individuals, using
Bayes’s theoremSpecificity X X x
Likelihood ratios for multicategory test X X X
ROC=receiver operating characteristic curve. *Numbered as described in text.
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Reasons for variability
Between test types or readers—Data should be
presented on the variability between different readers
or types of test and on tools to help calibration, such as
standard radiographs16 17 or laboratory quality control
measures. The extent to which other factors, such as
experience or training, affect reading adequacy is also
helpful.
Between subgroups of the study population—Data on
individuals should be available for determining the
influence on test performance of the following
variables: the spectrum of disease and non›disease (for
example by estimating “specificity” within each
category of “non›disease”); the effect of other test
results, taking account of logical sequencing of tests
(simplest, least invasive, cheapest are generally first);
any other characteristics (for example, age and sex)
that could influence test performance.
Between settings—Test performance needs to be
compared in several populations or centres, as has
been done for the general health questionnaire18 and
predictors of coma.19 Variability between settings can
also be explored across different studies by using meta›
analytic techniques.20 21 Studies should also explore the
following sources of variability between settings that
are not accounted for by the within›setting characteris›
tics outlined in the previous section. These sources may
be primary, secondary, or tertiary care; prevalence of
the target condition; country or time period. Residual
differences between settings should be explored to
judge the extent to which there is inexplicable variabil›
ity that may limit test applicability.
Summary
There is merit in studies with heterogeneous study
populations. They allow exploration of the extent to
which the performance of a diagnostic test depends on
prespecified predictors, and how much residual
variation exists. The more variation there is in study
populations, the greater the potential to know how the
test will perform in various settings.
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A tale of two blisters
In 1924, when I was 4 years old, there was an outbreak of
smallpox in Sunderland, my home town. Everyone was getting
vaccinated with three inoculations of cowpox vaccine scratched
into the skin over the deltoid area on the left arm. After a few
days three blisters would appear, while the surrounding area
became red and inflamed. To avoid pain, those who had been
vaccinated wore red ribbons on their arms to prevent other
people from bumping into them. As I had been vaccinated in
infancy, I did not require revaccination, but my mother knew that
I needed a red ribbon like everyone else so, as a wise parent, she
put one on my arm.
In September 1945 I was a surgeon lieutenant in the Royal
Navy in Ceylon when I was sent to Sumatra with a naval landing
party to Belawan Deli, the port for Medan, the principal city in
the northern part of the island. We were supposed to be getting
the Japanese out, but in fact we were getting the Dutch back in,
being protected from the Indonesians by armed Japanese
sentries. One day when I was walking down the village street I saw
a woman coming towards me wearing a red sarong and a red
turban. Her face and arms were covered with blisters. I
immediately decided that it must be smallpox, but then I quickly
thought it over and decided that if that was the diagnosis then she
should be much too ill to be walking around. I was so struck by
her appearance that I ran around the block, so that I could walk
past her again and get another look. I still could not see whether
there was umbilication of the blisters, which I had been taught
was a key diagnostic distinction between chickenpox and
smallpox, and I could not make a diagnosis. When I got back to
naval headquarters I asked a Dutch medical officer, and he told
me that it was yaws—a tropical spirochaetal disease that is a
probable variant of syphilis.
Blisters are seldom what they seem. Skimmed milk
masquerades as cream.
M G Jacoby Patchogue, New York, USA
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